Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

Share Price Information for Carrs Group (CARR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 131.00
Ask: 134.00
Change: -2.00 (-1.50%)
Spread: 3.00 (2.29%)
Open: 133.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
CARR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Animax Limited

21 Sep 2018 07:00

RNS Number : 4794B
Carr's Group PLC
21 September 2018
 

 

 

 

 

 

CARR'S GROUP PLC ("Carr's" or the "Group")

Acquisition of Animax Limited

Carr's Group bolsters its position in animal health with key acquisition

 

 

21 September 2018: Carr's (CARR.L), the Agriculture and Engineering Group, announces the acquisition of the entire issued share capital of Animax Limited ("Animax"), a producer of market-leading animal health products, for a total cash consideration of up to £8.5m.

 

Animax, based in Suffolk in the UK, was established in 1982. The business specialises in the research, development and manufacture of highly effective animal health products. Animax is at the forefront of innovation in the field of livestock trace element supplementation. Its patent-protected leaching boluses, currently sold in the UK and overseas under the Tracesure® and Allsure® brands, are specifically designed to deliver health benefits to livestock consistently over prolonged periods.

 

Animax also produces other leading animal health and trace element supplementation products sold under well-known brands including Copasure®, Copinox®, Coprac®, Easycal®, Pardevit® and Paracide®.

 

Highlights and strategic rationale of the acquisition:

 

The acquisition of Animax aligns with the Group's stated strategy of investing in growing agriculture markets in the UK and internationally.

 

In particular, Animax and its product ranges:

 

· enhance the Group's position in the global animal health and livestock supplementation markets;

· bring innovation and patent-protected technology to the Group together with a number of recognised and highly respected brands;

· are highly complementary to, and will benefit from clear synergies with, the established Carr's Group feed block business across the USA, NZ, Europe, UK and Ireland; and

· broaden the Group's animal health and supplementation product ranges which bring added value to farmers.

 

Carr's will support the growth and development of Animax through investment in research to develop new products and by investing in manufacturing efficiencies. In addition, Carr's expects significant manufacturing, distribution and sales synergy benefits to be realised as a result of the acquisition.

 

As part of the acquisition, Carr's has also acquired the entire issued share capital of Animax's related party, Clinimax Limited ("Clinimax"). Clinimax is a manufacturer of specialist disinfectant products for use in the medical industry and which also carry the benefit of patent-protection.

 

Both businesses are being acquired for an initial cash consideration of £6m, with an additional cash consideration of up to a maximum of £2.5m payable over the period to November 2020, based on the achievement of agreed financial targets.

 

For the year ended 30 November 2017, Animax and Clinimax in aggregate recorded EBITDA of £0.6m and profit before tax of £0.3m. The combined gross assets of Animax and Clinimax as at 30 November 2017 totalled £5.6m, including cash of £1.2m. The acquisition is expected to be earnings enhancing in the first full year of ownership. The total consideration is being satisfied by the Group's existing facilities.

 

Tim Davies, Chief Executive, commented:

 

"We are delighted to announce the acquisition of Animax. This acquisition is in line with our stated strategy of developing our offering in the growing livestock specialist nutrition market both in the UK and internationally. Animax is highly complementary to our global feed block business and will add value to our customers' businesses. Animax has a history of developing market leading products based on sound research with their brands being recognised for their efficacy and performance. The combination of Carr's resources, knowledge and distribution, together with the Animax research capability, product technology and history of innovation, make a compelling case for this strategic step for the Group."

 

 

 

 

Enquiries:

Carr's Group plc

Tim Davies (Chief Executive)

Neil Austin (Group Finance Director)

 

Tel: +44 (0) 1228 554 600

Powerscourt

Nick Dibden / Lisa Kavanagh / Sam Austrums

 

Tel: +44 (0) 20 7250 1446

 

About Carr's Group plc:

Carr's is an international leader in manufacturing value added products and solutions, with market leading brands and robust market positions in Agriculture and Engineering, supplying customers in over 50 countries around the world.

Its Agriculture division manufactures and supplies feed blocks and supplementation products for livestock, distributes farm machinery and runs a UK network of rural stores, providing a one-stop shop for the farming community. Its Engineering division designs and manufactures bespoke equipment and provides technical engineering services into the nuclear, petrochemical, oil and gas, pharmaceutical, process and renewable energy industries, including robotic and remote handling equipment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGMGZLGGKGRZZ
Date   Source Headline
12th Nov 20198:56 amRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSFinal Results
17th Oct 20194:35 pmRNSPrice Monitoring Extension
17th Oct 201911:00 amRNSNotice of Preliminary Results
9th Oct 20197:00 amRNSAppointment of Chairman Designate
23rd Sep 201910:38 amRNSBlock listing Application
23rd Aug 20199:30 amRNSDirector/PDMR Shareholding
20th Aug 201910:07 amRNSDirector/PDMR Shareholding
31st Jul 201910:43 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSTrading Update
11th Jul 20193:33 pmRNSBlock listing Interim Review
1st Jul 20197:03 amRNSAcquisition of NW Total Engineered Solutions
28th Jun 201912:02 pmRNSPrice Monitoring Extension
17th Jun 20194:40 pmRNSSecond Price Monitoring Extn
17th Jun 20194:35 pmRNSPrice Monitoring Extension
28th May 20192:41 pmRNSChange in Director Responsibilities
15th Apr 20197:00 amRNSInterim Results
26th Mar 20194:41 pmRNSSecond Price Monitoring Extn
26th Mar 20194:35 pmRNSPrice Monitoring Extension
18th Mar 201910:36 amRNSNotice of Interim Results
4th Feb 20194:58 pmRNSDirector/PDMR Shareholding
8th Jan 20194:42 pmRNSResult of AGM
8th Jan 20197:00 amRNSTrading Update
31st Dec 20187:00 amRNSBlock listing Interim Review
28th Dec 20184:41 pmRNSSecond Price Monitoring Extn
28th Dec 20184:35 pmRNSPrice Monitoring Extension
20th Dec 20188:29 amRNSDirector/PDMR Shareholding
18th Dec 20187:00 amRNSChairman Succession
30th Nov 20184:53 pmRNSDirector/PDMR Shareholding
30th Nov 201811:03 amRNSTotal Voting Rights
26th Nov 20185:04 pmRNSDirector/PDMR Shareholding
19th Nov 201811:25 amRNSDirector/PDMR Shareholding
12th Nov 20184:40 pmRNSSecond Price Monitoring Extn
12th Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20187:00 amRNSFull Year Results
31st Oct 201811:09 amRNSTotal Voting Rights
30th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 201811:11 amRNSNotice of Preliminary Results
11th Oct 20184:40 pmRNSSecond Price Monitoring Extn
11th Oct 20184:35 pmRNSPrice Monitoring Extension
21st Sep 20187:00 amRNSAcquisition of Animax Limited
6th Sep 20184:35 pmRNSPrice Monitoring Extension
31st Aug 201812:16 pmRNSTotal Voting Rights
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
18th Jul 20187:00 amRNSTrading Update
20th Jun 20187:00 amRNSBlock listing Interim Review
27th Apr 20183:38 pmRNSChange of Auditor
23rd Apr 20185:05 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.